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COMPARISON OF RADIOGRAPHIC HIP JOINT SPACE IN WEIGHT
BEARING AND SUPINE X-RAYS IN PATIENTS WITH HIP PATHOLOGY
M.J. Philippon, K.K. Briggs, P. Goljan, B.M. Devitt, L.P. Peixoto. Steadman
Philippon Res. Inst., Vail, CO, USA
Purpose: Hip arthroscopy is often used to treat many pathologies about
the hip. Diagnosis is based on history, physical examination and
radiographic ﬁndings. Studies have shown that decreased joint space
(2mm or less) in the hip is a negative prognostic factor for a favorable
outcome following arthroscopic treatment. The purpose of this study is
to investigate the potential inﬂuence of a patient's weight bearing
status (supine vs. standing) on radiographic joint space ﬁndings of the
hip.
Methods:Weight bearing and supine pelvic radiographs of 44 hip joints
were evaluated. All radiographs were evaluated twice by three
reviewers in order to determine intra and inter-observer reliability. The
average patient age was 36 (range 18 to 69), with 11 males and 11
females. The average BMI was 23. Joint space was measured at the
lateral edge, middle sourcil, and above the fovea of the hip. The ﬁrst
readings of a single reviewer were used in order to most closely mirror
the practices of a clinical setting. The measurements of the reviewer
with the highest intra-observer reliability were utilized.
Results: Intra-rater reliability for joint space measurements at the
lateral sourcil, middle sourcil, and fovea the weightbearing ﬁlms were
0.483, 0.679, 0.683 and for the supine ﬁlms were 0.718, 0.750, 0.697
respectively. Inter-rater reliability at the lateral sourcil, middle sourcil
and fovea for the weightbearing ﬁlms were 0.531, 0.627, and 0.410
respectively and for the supine ﬁlms were 0.475, 0.462, and 0.528
respectively. There was a signiﬁcant difference between joint space as
measured on weight bearing and supine radiographs at all three
measurement locations (lateral edge measurement P<0.001, middle
sourcil measurement P<0.001, and fovea measurement P<0.001). On
average, there was an increase of 0.50 mm[95%CI:0.28 to 0.71] at the
lateral sourcil, 0.46 mm[95%CI: 0.46 to 0.56] at the middle sourcil, and
0.92 mm [95%CI: 0.65 to 1.2] at the fovea from supine to weightbearing
measurements.
Conclusions: Supine radiographs had excellent intra-observer reli-
ability and all other measurements had moderate reliability. This study
demonstrated that an increased joint space was seen onweight bearing
pelvic radiographs compared to supine pelvic radiographs. Although
a statistically signiﬁcant difference was noted, the conﬁdence intervals
of the mean differences were less than 2mm and unlikely to alter
clinical decision making in the majority of cases. As there is an increase
in joint space onweightbearing ﬁlms, it is possible that a joint space of 2
mm or less could go undetected and supine radiographs allowed for
improved intra-observer reliability, this study supports the use of
supine ﬁlms for measurement of hip joint space so that t joint space
narrowing can be appreciated.Ă386
COMPARING T2 CALCULATION TECHNIQUES
J.K. Riek, V. Shah. VirtualScopics, Inc, Rochester, NY, USA
Purpose: T2 relaxation time in cartilage provides useful measurements
as it relates to hydration, macromolecular density and collagen ﬁber
orientation. The three major manufacturers of MRI scanners all provide
sequences and software that can be used to generate T2 maps. In
addition, there are many techniques presented in the literature for
calculating T2 relaxation times. This study compares the results from
various methods with those generated by the manufacturers and draws
conclusions about the preferred methods to use.
Methods: Four volunteer subjects were scanned on two different MR
scanners (Siemens Trio 3T and GE Signa HDxt 1.5T). On each scanner,
a T2 mapping sequence was used to scan the medial condyle of the left
knee. All subjects were scanned twice on each scanner with reposi-
tioning of the patient between scans. Each scan contained ﬁve vials with
nominal T2 relaxation times of 15, 30, 60, 120 and 240 ms in addition to
the medial condyle. T2 values were calculated with and without the
ﬁrst echo, and with and without a signal bias.
Results: Results are currently being compiled. The different techniques
have widely varying T2 relaxation times, especially at the higher T2
relaxation times. Altering the signal bias has minimal effect if the
proton density is high (phantoms), but has a substantial effect in areas
of lower signal intensity (cartilage).
Conclusions: Regardless of the method employed to calculate T2
relaxation time, if longitudinal measurements are begin made, then the
same technique needs to be used across all visits. In addition, in a multi-
center study, the same technique should be used to minimize vari-
ability. Based upon the knownT2 relaxation times within the phantoms,
central calculation dropping the ﬁrst echo and accounting for some
signal bias provides the most accurate results387
THE PREVALENCE AND PROGRESSION OF RADIOGRAPHIC KNEE
OSTEOARTHRITIS OVER 9 YEARS IN A POPULATION-BASED COHORT
OF MIDDLE-AGED SUBJECTS
J. Kumm, A. Tamm, M. Lintrop, A. Tamm. Univ. of Tartu, Tartu, Estonia
Purpose: To investigate the prevalence and progression of radiographic
knee osteoarthritis (KOA) over 9 years in middle-aged subjects with
chronic knee pain.
Methods: In longitudinal population-based study, tibio-and patellofe-
moral (TF/PF) radiographs were graded for OA in 113 subjects (mean age
45 6.2 years) at four different time points over 2002-2011. Radiographic
progression was deﬁned as: (i) the presence of osteophytes and/or joint
space narrowing (JSN) in subjectswith no previous radiographic OAor (ii)
an increase in the grade or number of osteophytes and/or JSN grade.
Results: At baseline, 55% (62/113) of subjects had KOA, the majority of
them with OA grade 1. Out of the subjects with KOA, 36 had only osteo-
phytes (58 %), 8 had only JSN (13%) and in 18 cases (29%) the OA grade
based on osteophytes and JSN in combination. More than 1/3 of subjects
had only PF joint involvement. The progression rate of radiographic KOA
over 9 years was 69% (78/113). Among them 26 had only TFOA progres-
sion, 23 only PFOA progression and 29 had TFOA and PFOA progression in
combination. In 57% of subjects KOA progression was based on osteo-
phytes alone, in 17% on isolated JSN, and in 26% on both. Individual
assessment revealed distinct subgroups of radiographic progression.
Conclusions: More than half of the middle-aged subjects with chronic
knee pain had radiographic KOA. The radiographic course of early KOA
over 9 years turned out to be non-consistent with intermittent periods
of progression and stabilization.388
IMPACT OF CHONDROITIN SULFATE TREATMENT ON
IMMUNOREGULATORY NEUROPEPTIDES LEVELS IN OA PATIENTS
SYNOVITIS
S. Pérez-García y, L. Tio z, F. Montañés x, P. Benito x, Y. Juarranz y, R.P.
Gomariz y, J. Monfort x. yUniv. Complutense de Madrid, Madrid, Spain;
zGRICIC.FIMIM, Barcelona, Spain; xHosp. del Mar, Barcelona, Spain
Purpose: Osteoarthritis (OA) is the most prevalent joint disease, char-
acterized by synovial inﬂammation, cartilage destruction and sub-
chondral bone sclerosis. Synovitis has been described to be an
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S205important process in OA progression, where several immunemediators,
such as immunoregulatory neuropeptides, play an important role. The
vasoactive intestinal peptide (VIP) and the corticotropin-releasing
factor (CRF)/urocortins (UCNs) family are neuropeptides expressed in
central and peripheral tissues, including immune cells, that modulate
the expression of inﬂammatory and extracellular matrix remodelling
mediators. VIP has previously shown a plethora of beneﬁcial effects,
both in inﬂammatory disorder animal models and in human OA, being
a potential therapeutic agent. Besides, it has shown that high VIP levels
are correlated with a decrease of the OA severity progress. In addition,
CRF and Urocortin1 (UCN1) are secreted to the OA joint microenvi-
ronment exerting an autocrine and paracrine immuno/inﬂammatory
regulation. Chondroitin sulfate (CS) is a Symptomatic Slow Action Drug
for Osteoarthritis (SYSADOA) described to improve the symptoms of OA
disease. The NIH-funded GAIT study demonstrated that CS is an effec-
tive drug in reducing OA patients’ synovitis. The aim of this study was to
compare the effect of CS vs. paracetamol on synovitis in OA patients,
and to evaluate their impact on VIP, CRF and UCN1 concentrations.
Methods: 71 OA patients with synovitis (synovial hyper-
trophy+effusion4mm) were treated with CS (Condrosan, CS Bio-
ActiveTM, Bioibérica S.A., Barcelona, Spain) (800mg/day) or para-
cetamol (4g/day) for 6 months. Patients were followed-up until month
9 to evaluate the CS carry-over effect. In each visit (0, 6 and 9 months)
synovitis was evaluated by sonography and plasma and synovial ﬂuid
were collected for the quantiﬁcation of VIP, CRF and UCN1 by EIA
(Enzyme Immunoassay). Once the clinical data have been collected, CS
treated patients were subdivided into two groups, as responding and
non-responding to treatment. A responding patient was deﬁned by
a sinovitis reduction at 6 months greater than 20% from basal value.
Time-course analysis study was performed by a Wilcoxon two-related
samples test. The comparation between responding and non-
responding patients was analyzed by a Mann-Whitney U test. P values
less than or equal to 0.05 were considered signiﬁcant.
Results: The analysis of the results obtained showed that CS but not
paracetamol reduces effectively the synovitis observed in OA patients.
The improvement remained after 3 months treatment cessation.
Synovial ﬂuid presents a progressive decrease neuropeptides levels
along the CS treatment, reaching signiﬁcancy VIP reduction at 9
months. This tendency is more pronounced when only the responding
patients are analyzed. In contrast no tendency was observed with the
paracetamol group, showing a lonely signiﬁcant decrease of UCN1 at 6
months. The neuropeptides levels in plasma did not show signiﬁcant
differences neither in the chondroitin treated patients nor in the
responding group. However, the paracetamol grup present a progres-
sive increment of CRF/UCN levels being signiﬁcant the UCN1 increase at
9 months. When comparing the basal levels of the neuropeptides
between responding and non-responding CS groups, we observed that
patients with high level of neuropeptides before CS treatment,
demonstrated a positive response to the treatment.
Conclusions: These results indicate that CS but not paracetamol
effectively reduces synovitis, even after leaving the CS treatment. This
improvement lead to a decreased VIP level in synovial ﬂuid, probably
because of a fall of the mediators that regulates its expression.
Neuropeptides levels could represent an important biomarker to
distinguish which patients are responder to CS, since high level of them
in synovial ﬂuid at the onset of treatment are correlated with a positive
response to CS treatment.Figure 1a. Cytokine Production from THP - 1 Macrophages After 24 Hours. 1b: Rela-
tionship between Chondroitin Sulphate (CS) Treatment Groups and IL-1b Production
by THP - 1 Macrophages at 24 Hours.389
THE EFFECTS OF CHONDROITIN SULPHATE ON INFLAMMASOME
ACTIVATION
E.W. Orlowsky y, T.V. Stabler y, E. Montell z, J. Vergas z, V.B. Kraus y. yDuke
Univ. Med. Ctr., Durham, NC, USA; z Pre-Clinical R&D Area, PharmaSci. Div.,
Bioibérica, Barcelona, Spain
Purpose: Chondroitin Sulphate (CS), a natural glycosaminoglycan of the
cartilage extracellular matrix, has been shown to have some clinical
beneﬁt in symptomatic osteoarthritis (OA). While both OARSI and
EULAR have endorsed its use in certain types of OA, the exact mecha-
nism of action of CS is still unclear. Prior studies have shown that high
levels of CS could potentially cause precipitation of monosodium urate
(MSU) crystals leading to activation of the inﬂammasome. In vitro
studies have shown that CS has some anti-inﬂammatory effects on
chondrocytes and synoviocytes from OA patients. However, the effect of
CS on macrophages remains unclear and macrophages play a centralrole in OA pathogenesis. The purpose of our study was to evaluate the in
vitro effects of CS on cytokine production by macrophages.
Methods:We established an in vitro cell culture system using a human
monocytic cell line, THP-1(ATCC TIB-202). These cells were induced to
differentiate into mature macrophages using 12-O-tetradecanoyl-
phorbol-13-acetate (Enzo Life Sciences). To test the effects of CS on uric
acid (UA) solubility, we incubated sterile solutions of CS/UA is optimum
at various concentrations (CS 10-10000mg/ml & UA 10-500mg/ml). These
solutions were added to the macrophages in vitro to monitor for pro-
inﬂammatory effects; the solutions were also subjected to high speed
centrifugal ultra-ﬁltration to quantify, by HPLC, potential particulate
formation through analysis of the remaining soluble UA in the super-
natant. MSU crystals (Enzo Life Sciences) were used as a positive control
pro-inﬂammatory stimulus. Medium from the cultured cells was
removed at 6 and 24 hours and analyzed by immunoassay (R&D
Systems) for IL1b. These experiments were repeated with various
concentrations of a caspase-1 inhibitor (0.01mM-10mM, EMD Millipore)
to identify the component of IL1b production attributable to inﬂam-
masome activation. Finally, to test for anti-inﬂammatory effects of CS,
macrophages were pretreated with highly puriﬁed bovine CS (Bio-
ibérica, Barcelona, Spain) for 4 hours prior to the addition of MSU
crystals (200mg/ml) or Lipopolysaccharide (LPS) at 50mg/ml, which
served as a positive control. A range of doses of CS in the physiologic
range (10-200mg/ml) were tested. Culture medium was collected at 6
and 24 hours and IL1b levels were determined as above. Results were
analyzed using Graph Pad and linear trend analysis.
